Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Demand Drivers: Increasing Prevalence of Diabetes: The growing global prevalence of type 2 diabetes is a major factor driving the demand for GLP-1 receptor agonists
10.1038/s41598-021-00337-z 66 GoldenbergD
Treatment typically begins with a 2.5 mg dose for 4 weeks to improve gastrointestinal tolerability, followed by gradual dose increases every 4 weeks as tolerated, up to a maximum of 15 mg weekly
While these effects are beneficial, the adjustment period can temporarily affect your energy levelsespecially during the first few weeks of treatment or when your dosage increases
US$ 27.72
US$ 25.90
US$ 21.28
US$ 27.35
US$ 22.00
US$ 26.85
US$ 27.21
